MARKET

ORMP

ORMP

Oramed Pharmaceuticals Inc
NASDAQ
2.320
+0.050
+2.20%
After Hours: 2.320 0 0.00% 16:05 05/02 EDT
OPEN
2.270
PREV CLOSE
2.270
HIGH
2.350
LOW
2.270
VOLUME
51.19K
TURNOVER
--
52 WEEK HIGH
3.090
52 WEEK LOW
1.820
MARKET CAP
94.77M
P/E (TTM)
-4.9700
1D
5D
1M
3M
1Y
5Y
1D
Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical
Seeking Alpha · 4d ago
Alpha Tau enters strategic marketing alliance with Oramed
TipRanks · 4d ago
Oramed announces $36.9M investment and collaboration with Alpha Tau
TipRanks · 4d ago
Oramed Pharma Closes Strategic Investment In Alpha Tau Medical; Oramed Affiliate Purchases About 14.1M Alpha Tau's Ordinary Shares $2.612/Shr
Benzinga · 4d ago
ORAMED PHARMACEUTICALS ANNOUNCES $36.9 MILLION INVESTMENT AND STRATEGIC COLLABORATION WITH ALPHA TAU MEDICAL
Reuters · 4d ago
ALPHA TAU ANNOUNCES CLOSING OF $36.9 MILLION REGISTERED DIRECT OFFERING AND STRATEGIC MARKETING ALLIANCE WITH ORAMED PHARMACEUTICALS
Reuters · 4d ago
Weekly Report: what happened at ORMP last week (0421-0425)?
Weekly Report · 4d ago
Weekly Report: what happened at ORMP last week (0414-0418)?
Weekly Report · 04/21 10:28
More
About ORMP
More
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.
Recently
Symbol
Price
%Change

Webull offers Oramed Pharmaceuticals, Inc. stock information, including NASDAQ: ORMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORMP stock methods without spending real money on the virtual paper trading platform.